Canada markets open in 1 hour 24 minutes

Adial Pharmaceuticals, Inc. (ADIL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4000+0.0350 (+2.56%)
At close: 04:00PM EDT
1.4500 +0.05 (+3.57%)
Pre-Market: 08:01AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.3650
Open1.3500
Bid1.3300 x 200
Ask1.4400 x 200
Day's Range1.2800 - 1.4299
52 Week Range0.7700 - 14.0000
Volume185,136
Avg. Volume4,062,829
Market Cap2.329M
Beta (5Y Monthly)1.52
PE Ratio (TTM)N/A
EPS (TTM)-8.9800
Earnings DateMar 28, 2024 - Apr 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.00
  • Zacks

    Is Masimo (MASI) Outperforming Other Medical Stocks This Year?

    Here is how Masimo (MASI) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.

  • GlobeNewswire

    Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

    CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 1,150,000 shares of common stock of the Company originally issued in October 2023

  • GlobeNewswire

    Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

    New patent strengthens Adial’s patent portfolio and covers AD04’s unique ability to target the serotonin transporter gene for the potential treatment of opioid use disorderCHARLOTTESVILLE, Va., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 11,905,562 was issue